Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease

International Journal of Cardiology

Volumn 89, Issue 2-3, 2003, Pages 173-178

  Wykretowicz, A ^a   Dziarmaga, M ^b   Szczepanik, A ^a   Guzik, P ^a   Wysocki, H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Department of Cardiology   (Poland)

Author keywords

Angioplasty; Lipid peroxidation; Nitric oxide; Restenosis

Indexed keywords

HYDROPEROXIDE; LIPID HYDROPEROXIDE; NITRATE; NITRIC OXIDE; NITRIC OXIDE REDUCTASE; NITROUS OXIDE; REAGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BIOASSAY; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; EVALUATION; FEMALE; FOLLOW UP; HEMOCONCENTRATION; HUMAN; LIPID PEROXIDATION; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTENOSIS; STABLE ANGINA PECTORIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0038736798     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00472-2     Document Type: Article

References (19)

1. Blum A., Vardinon N., Kaplan G., et al. Autoimmune and inflammatory responses may have an additive effect in postpercutaneous transluminal coronary angioplasty restenosis. Am J Cardiol. 81:1998;339-341.
2. Berlinger J.A., Navab M., Fogelman A.M., et al. Atherosclerosis. Basic mechanisms. Oxidation, inflammation and genetics. Circulation. 91:1995;2488-2496.
3. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol. 31:1998;1460-1465.
4. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:2001;1014-1021.
5. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witzum J.L. Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med. 320:1989;915-924.
6. Iwashina M., Shichiri M., Marumo F., et al. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation. 98:1998;1212-1218.
7. Janero D.R., Ewing J.F. Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential. Free Radic Biol Med. 29:2000;1199-1221.
8. Weintraub W.S., Kosinski A.S., Brown C.L., King S.B. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 21:1993;6-14.
9. Liu M.W., Roubin G.S., King S.B. III. Restenosis after coronary angioplasty. Potential biological determinants and the role of intimal hyperplasia. Circulation. 79:1989;1374-1387.
10. Clowes A.W., Clowes M.M., Fingerle J., Reidy M.A. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest. 60:1989;360-364.
11. Schini-Kerth V.B., Bassus S., Fisslthaler B., et al. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-β1 and platelet derived growth factor AB. Circulation. 96:1997;3888-3896.
12. Fingerle J., Johnson R., Clowes A.W., et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA. 86:1989;8412-8416.
13. Yao S., Ober J.C., Krishnaswami A.K., et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 86:1992;1302-1309.
14. Wang B.Y., Candipan R.C., Arjomandi M., et al. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol. 28:1996;1573-1579.
15. Laurindo F.R., da Luz P.L., Uint L., Rocha T.F., Jaeger R.G., Lopes E.A. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation. 83:1991;1705-1715.
16. Penn M.S., Mei-Zhen C., Winokur A.L., et al. Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation. Blood. 96:2000;3056-3063.
17. Tardif J.C., Cote G., Lesperance J., et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 337:1997;365-372.
18. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem. 220:1994;403-409.
19. Maffia P., Ianaro A., Sorrentino R., et al. Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis. Arterioscler Thromb Vasc Biol. 22:2002;263-267.